Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LlcfiledCriticalWyeth Llc
Priority to CU20100047ApriorityCriticalpatent/CU20100047A7/es
Publication of CU20100047A7publicationCriticalpatent/CU20100047A7/es
208000012902Nervous system diseaseDiseases0.000abstract1
208000015114central nervous system diseaseDiseases0.000abstract1
150000001875compoundsChemical class0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona un compuesto de fórmula I y su uso para el tratamiento de un trastorno del sistema nervioso central relacionado con, o que se ve afectado por, el receptor de la histamina-3.
CU20100047A2010-03-122010-03-12Derivados de azaciclilisoquinolinona e-isoindolinona como antagonistas de la histamina-3
CU20100047A7
(es)